Agilent Technologies Inc vs AGNC Investment Corp — how do they compare? Agilent Technologies Inc trades at $149.35 (market cap $42.00B), while AGNC Investment Corp trades at $10.9 (market cap $12.74B). The key difference: Agilent Technologies Inc is far larger — about 3.3× AGNC Investment Corp's market cap, and AGNC Investment Corp pays the higher dividend (13.4%). Which is the better fit depends on your goals.
| A | AGNC | |
|---|---|---|
Market Cap | $42.00B | $12.74B |
Sector | Health | Financials |
52-Week High | $157.20 | $12.17 |
52-Week Low | $110.24 | $9.46 |
Enterprise Value | $43.55B | — |
Dividend Yield | 0.69% | 13.4% |
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $145.97, up 3.28% in the last session, with a bullish technical outlook from moving averages but overbought RSI levels. The company reported strong Q1 2026 earnings, beating estimates with EPS of $1.49, and maintains solid profitability with a net income margin of 19.55%. Recent developments include FDA and EU approvals for diagnostic assays and the acquisition of Biocare Medical, enhancing its healthcare portfolio.
The stock offers upside to the consensus price target of $154.90, supported by analyst optimism (77.5% buy ratings), but high valuation ratios like a P/E of 146.56 pose risks. Investors should monitor execution of growth initiatives and competitive pressures in the life sciences sector, with earnings on August 26, 2026, as a key catalyst.
AGNC Investment trades at $10.84, up 2.17% today, with a bullish technical signal and strong earnings beats in Q1 and Q2 2026. The stock offers a high dividend yield, with consistent monthly payouts, and trades at a P/E of 5.39 and P/B of 1.22. Recent news highlights its 13%+ yield and stable dividend history, though analyst consensus is mixed with a Hold majority.
Outlook remains positive due to robust net income margins above 94% and economic returns, but risks include interest rate sensitivity and leveraged mortgage securities. The consensus price target of $11.30 suggests modest upside, supported by institutional interest and earnings momentum, though volatility from macroeconomic factors warrants caution.
Trailing returns across standard periods
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →AGNC Investment Corp is a real estate investment trust that invests in agency residential mortgage-backed securities. The firm's asset portfolio is comprised of residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by a U.S. Government-sponsored enterprise, such as the Federal National Mortgage Association and the Federal Home Loan Mortgage Corporation, or by a U.S. Government agency, such as the Government National Mortgage Association. It also invests in other types of mortgage and mortgage-related residential and commercial mortgage-backed securities or other investments in or related to, the housing, mortgage or real estate markets.
Read more on AGNC →